Effect of Immunomodulating Extract and Some Isolates from Etlingera rubroloba A.D. Poulsen Fruits on Diabetic Patients with Tuberculosis.
Muhammad Ilyas YIdin SahidinAsriullah JabbarAgung W M YodhaAjeng DiantiniIvan Surya PradiptaRiezki AmaliaRaden Maya FebriantiYuni Elsa HadisaputriMohammad GhozaliEuis JulaehaPublished in: Molecules (Basel, Switzerland) (2023)
Diabetes mellitus (DM) is a disease easily complicated by tuberculosis (TB) due to impaired function of the innate immune response. The successes of the discovery of immunomodulatory compounds needs to be continued to introduce new insights into the innate immune response. In previous studies, plant compounds of Etlingera rubroloba A.D. Poulsen ( E.rubroloba ) were demonstrated to have potential as an immunomodulators. This study aims to isolate and identify the structure of the compounds of E.rubroloba fruit that could effectively improve the function of the innate immune response in individuals with DM infected with TB. The isolation and purification of the compounds of the E.rubroloba extract were carried out by radial chromatography (RC) and thin-layer chromatography (TLC). Identification of the isolated compound structures was determined by measuring the proton ( 1 H) and carbon ( 13 C) nuclear magnetic resonance (NMR). In vitro testing was performed on the immunomodulating activity of the extracts and isolated compounds on DM model macrophages infected with TB antigens. This study succeeded at isolating and identifying the structures of two isolate compounds, namely Sinaphyl alcohol diacetat (BER-1), and Ergosterol peroxide (BER-6). The two isolates were more effective as immunomodulators than the positive controls were, which differed significantly (* p < 0.05) at the reducing interleukin-12 (IL-12) levels and Toll-like receptor-2 (TLR-2) protein expression and increasing the human leucocyte antigen-DR (HLA-DR) protein expression in DM infected with TB. The isolated compound was discovered in E. rubroloba fruits, which has been reported to have the potential to be developed as an immunomodulatory agent. Follow-up testing to determine the mechanism and effectiveness of these compounds as immunomodulators for DM patients is required so that they are not susceptible to TB infection.
Keyphrases
- immune response
- toll like receptor
- mycobacterium tuberculosis
- magnetic resonance
- dendritic cells
- high resolution
- mass spectrometry
- glycemic control
- inflammatory response
- randomized controlled trial
- oxidative stress
- systematic review
- newly diagnosed
- endothelial cells
- high speed
- risk assessment
- ejection fraction
- human health
- hiv aids
- ms ms
- skeletal muscle
- weight loss
- human immunodeficiency virus
- liquid chromatography
- tandem mass spectrometry
- hiv infected
- antiretroviral therapy
- recombinant human